Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients.
Holicek P, Truxova I, Rakova J, Salek C, Hensler M, Kovar M, Reinis M, Mikyskova R, Pasulka J, Vosahlikova S, Remesova H, Valentova I, Lysak D, Holubova M, Kaspar P, Prochazka J, Kasikova L, Spisek R, Galluzzi L, Fucikova J.
Holicek P, et al. Among authors: hensler m.
Cell Death Dis. 2023 Mar 24;14(3):209. doi: 10.1038/s41419-023-05728-w.
Cell Death Dis. 2023.
PMID: 36964168
Free PMC article.